| Family Vision Care, Inc. | |
|
2106 Oxford St, Missoula, MT 59801-6638 | |
| (406) 549-2541 | |
| Not Available |
| Full Name | Family Vision Care, Inc. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2106 Oxford St, Missoula, Montana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205958717 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 692 OPT (Montana) | Primary |
| Provider Name | William E Thomas |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275543225 PECOS PAC ID: 3971695370 Enrollment ID: I20070815000157 |
News Archive
The Aesthetic Surgery Education and Research Foundation announced this week results of a new study that showed patients have significant and sustained improvements in body image after surgery.
The team led by a Duke University scientist has identified three bile acids produced by gut bacteria that were evident in people who responded well to a common cholesterol-lowering drug called simvastatin. The finding, published Oct. 13, 2011, in PLoS One, demonstrates how gut bacteria can cause inherent differences in the way people digest, metabolize and benefit from substances such as drugs.
The world's first and largest group medical practice and one of the nation's premier volunteer service organizations of professional African American women are joining forces to eradicate health disparities among communities of color in the United States. Mayo Clinic and The Links, Incorporated have established a formal collaboration that aims to develop a more diverse health care workforce.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
In one of the big NHS blunders, nearly 800,000 people who have pledged one or more of their organs for donation may have had their preferences of which organ/s recorded incorrectly for the past 10 years. There are nearly 17 million donors who consent to give all their organs. However some have preferences and withhold consent for some organs like eyes, skin or heart etc. Some had also expressed their wish that their body tissue should not be used in research after their death. This huge error came to public notice in 2009 when the NHS Blood and Transplant started sending out mails to potential donors to check their preferences. Many people wrote back that the information in the records were not right.
› Verified 2 days ago
| Provider Name | Kellie Hadnot |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1093979619 PECOS PAC ID: 4082781513 Enrollment ID: I20100629000900 |
News Archive
The Aesthetic Surgery Education and Research Foundation announced this week results of a new study that showed patients have significant and sustained improvements in body image after surgery.
The team led by a Duke University scientist has identified three bile acids produced by gut bacteria that were evident in people who responded well to a common cholesterol-lowering drug called simvastatin. The finding, published Oct. 13, 2011, in PLoS One, demonstrates how gut bacteria can cause inherent differences in the way people digest, metabolize and benefit from substances such as drugs.
The world's first and largest group medical practice and one of the nation's premier volunteer service organizations of professional African American women are joining forces to eradicate health disparities among communities of color in the United States. Mayo Clinic and The Links, Incorporated have established a formal collaboration that aims to develop a more diverse health care workforce.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
In one of the big NHS blunders, nearly 800,000 people who have pledged one or more of their organs for donation may have had their preferences of which organ/s recorded incorrectly for the past 10 years. There are nearly 17 million donors who consent to give all their organs. However some have preferences and withhold consent for some organs like eyes, skin or heart etc. Some had also expressed their wish that their body tissue should not be used in research after their death. This huge error came to public notice in 2009 when the NHS Blood and Transplant started sending out mails to potential donors to check their preferences. Many people wrote back that the information in the records were not right.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Family Vision Care, Inc. 2106 Oxford St, Missoula, MT 59801-6638 Ph: (406) 549-2541 | Family Vision Care, Inc. 2106 Oxford St, Missoula, MT 59801-6638 Ph: (406) 549-2541 |
News Archive
The Aesthetic Surgery Education and Research Foundation announced this week results of a new study that showed patients have significant and sustained improvements in body image after surgery.
The team led by a Duke University scientist has identified three bile acids produced by gut bacteria that were evident in people who responded well to a common cholesterol-lowering drug called simvastatin. The finding, published Oct. 13, 2011, in PLoS One, demonstrates how gut bacteria can cause inherent differences in the way people digest, metabolize and benefit from substances such as drugs.
The world's first and largest group medical practice and one of the nation's premier volunteer service organizations of professional African American women are joining forces to eradicate health disparities among communities of color in the United States. Mayo Clinic and The Links, Incorporated have established a formal collaboration that aims to develop a more diverse health care workforce.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
In one of the big NHS blunders, nearly 800,000 people who have pledged one or more of their organs for donation may have had their preferences of which organ/s recorded incorrectly for the past 10 years. There are nearly 17 million donors who consent to give all their organs. However some have preferences and withhold consent for some organs like eyes, skin or heart etc. Some had also expressed their wish that their body tissue should not be used in research after their death. This huge error came to public notice in 2009 when the NHS Blood and Transplant started sending out mails to potential donors to check their preferences. Many people wrote back that the information in the records were not right.
› Verified 2 days ago
Mark Wayne Mutter Ii, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 700 W Kent Ave, Missoula, MT 59801 Phone: 406-541-3937 Fax: 406-541-3811 | |
Thomas R Ferguson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2510 S Reserve St, Missoula, MT 59801 Phone: 406-721-5925 Fax: 406-721-3859 | |
Ty William Felton, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2230 N Reserve St Ste 330, Missoula, MT 59808 Phone: 406-309-6633 Fax: 406-309-6644 | |
Dr. Kellie Marie Hadnot, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2106 Oxford St, Missoula, MT 59801 Phone: 406-549-2541 | |
Dr. Heidi Gail Brott, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4000 Us Highway 93 S, Missoula, MT 59804 Phone: 406-251-3679 Fax: 406-251-3715 | |
Shopko Optical 075 Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2510 S Reserve St, Missoula, MT 59801 Phone: 406-721-4646 | |
Sandy Sheppard Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 700 South Ave W, Ste. G, Missoula, MT 59801 Phone: 406-549-4851 Fax: 406-549-8486 |